跳至主要内容
临床试验/ACTRN12619001360101
ACTRN12619001360101终止未知

Assessing the effect of melatonin on sleep behaviour and executive functioning in children with Fetal Alcohol Spectrum Disorder

Griffith University0 个研究点目标入组 9 人开始时间: 2019年10月3日最近更新:
适应症

试验速览

阶段
未知
状态
终止
入组人数
9

研究概览

简要总结

Data being processed

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
5 Years 至 12 Years(—)
性别
All

入选标准

  • Children aged between 5- and 12-years with confirmed prenatal alcohol exposure and who have been assessed using the Australian Guidelines for the diagnosis of FASD to have either FASD with 3 Sentinel Facial Features (SFF); FASD with < 3 SFF or At Risk” of FASD (Bower & Elliott, 2016), and with reported sleep problems (see Inclusion Criteria).
  • Sleep Problem Inclusion Criteria
  • Children will be included in the study if their parents/caregivers report that they have problems with sleep initiation, whereby sleep onset latency is equal to or greater than 30 minutes, three nights or more a week, for equal to or more than three months.

排除标准

  • 1) Are not currently receiving sedative medications,
  • 2) Who have changed place of residence or primary carers in the last three months (as this instability may be contributing to sleep problems independent from FASD).
  • 3) Have been diagnosed with Type 1 diabetes.

研究者

相似试验